Richa Gupta

While melatonin is widely considered a benign over-the-counter sleep aid, a recent large observational study suggests that chronic use (≥12 months) may be associated with a significantly increased risk of incident heart failure, hospitalisation, and mortality in adults with insomnia. These findings—presented at the American Heart Association (AHA) Scientific Sessions 2025—raise important questions about the long-term cardiovascular safety of melatonin. Given the study’s observational...

Artificial Intelligence ( AI ) is revolutionizing the understanding, diagnosis, and treatment of Alzheimer’s disease, promising earlier detection, better patient stratification, and accelerated drug discovery. Here is a comprehensive overview of how AI is transforming Alzheimer’s care in 2025 Early Detection of Alzheimer's Early Diagnosis and Risk Prediction in Alzheimer's AI has enabled the identification of early risk factors by analyzing large-scale patient data—including electronic health...

TAR-200 is a groundbreaking, pretzel-shaped drug-device designed to transform the treatment landscape for patients with high-risk...